Increase in plasma concentration of amisulpride after addition of concomitant lithium.
Bergemann
Niels
N
Abu-Tair
Fatima
F
Kress
Kai R
KR
Parzer
Peter
P
Kopitz
Jürgen
J
D000328:Adult; D000077582:Amisulpride; D018692:Antimanic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001883:Borderline Personality Disorder / Q000188:drug therapy; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D013469:Sulpiride / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D013469:Sulpiride; D000077582:Amisulpride